Clinical Trials Logo

Filter by:
NCT ID: NCT02464137 Terminated - Clinical trials for Squamous Cell Carcinoma of the Larynx

HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer

HYDRA
Start date: April 27, 2015
Phase: Phase 1
Study type: Interventional

single-modality phase I dose escalation toxicity study for first-line curative treatment of head and neck squamous cell carcinoma.

NCT ID: NCT02462837 Terminated - Pain Clinical Trials

Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement

Start date: May 2015
Phase: Phase 2
Study type: Interventional

The objective of this pilot study is to assess whether Myrbetriq™ will improve post-operative ureteral pain and discomfort, reduce bladder storage symptoms and increase quality of life following ureteral stenting.

NCT ID: NCT02462759 Terminated - Clinical trials for Spinal Muscular Atrophy

A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA).

EMBRACE
Start date: August 19, 2015
Phase: Phase 2
Study type: Interventional

The primary objective of Part 1 of this study is to assess the safety and tolerability of Nusinersen in participants with SMA who are not eligible to participate in the clinical studies ISIS 396443-CS3B (NCT02193074) or ISIS 396443-CS4 (NCT02292537). The secondary objective of Part 1 of this study is to examine the pharmacokinetics (PK) of Nusinersen in participants with SMA. The primary objective of Part 2 of this study is to assess the long-term safety and tolerability of Nusinersen in participants with SMA who participated in Part 1 and completed their End of Part 1 Evaluation assessments. The secondary objective of Part 2 of this study is to examine the PK of Nusinersen in participants with SMA who participated in Part 1 and completed their End of Part 1 Evaluation assessments.

NCT ID: NCT02462525 Terminated - Multiple Myeloma Clinical Trials

Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma

Start date: May 6, 2015
Phase: Phase 1
Study type: Interventional

This is a Phase 1/1b, open-label, dose-escalation study designed to evaluate the safety, pharmacokinetics, and to determine the recommended Phase 2 dose of ABBV-838 in subjects with relapsed and refractory multiple myeloma.

NCT ID: NCT02462200 Terminated - Breast Cancer Clinical Trials

Shave Margins in Breast Conservation Therapy

SMART
Start date: June 13, 2016
Phase: Phase 2
Study type: Interventional

The investigators propose a randomized controlled superiority trial of standard breast-conserving surgery (BCS) versus BCS with cavity shave margins (CSM). The main objectives of this trial will be to evaluate prospectively the impact of routine standardized CSM on margin status following primary surgery for early stage breast cancer (Stage 0 - II), on post-operative patient satisfaction and cosmetic outcomes, and on general intraoperative time and operative costs. A parallel group format will be implemented to compare this modified surgical therapy - BCS with CSM - with BCS alone, which is the current standard of care.

NCT ID: NCT02461784 Terminated - Clinical trials for Inflammatory Bowel Disease (IBD)

The Effect of Methotrexate on Sperm Quality in Men With Inflammatory Bowel Disease

Start date: January 21, 2016
Phase:
Study type: Observational

Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract which includes Crohn's disease (CD) and ulcerative colitis (UC) which peak in incidence (rate or frequency) during the reproductive years. An increasing number of young people will face challenging decisions regarding medical management of this chronic disease during a period of time when they are still completing schooling, establishing their career, and/or are building a family. Treatment options for IBD consist of immunosuppressive therapy, such as immunomodulators (azathioprine and methotrexate). Methotrexate (MTX) is a folic acid antagonist (a substance that interferes with or inhibits the action of another). It is thought that MTX works by decreasing the inflammation in the gastrointestinal tract. MTX has been studied for many years and in used as treatment in not only IBD, but also in conditions such as rheumatoid arthritis and lupus. However, due to concerns about the safety of MTX, particularly in regards to fertility and pregnancy has limited its current use. Participants are invited to take part in this research project to determine whether the treatment of IBD patients with MTX is associated with an increased risk for infertility. Investigators will recruit 75 male IBD patients under MTX treatment for their IBD as well as 75 healthy male controls for a total of 150 patients at the University of Wisconsin Hospital & Clinics.

NCT ID: NCT02461433 Terminated - Obesity Clinical Trials

Surgical Application of Vac Dressings In Obese Patients to Reduce Wound Complications

SAVIOR
Start date: June 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether application of an incisional wound Prevena trademark (TM) dressing (applies negative pressure to wounds) in the obese (BMI ≥30) surgical patient will reduce surgical site infections (SSI) when compared to the standard of care dressing.

NCT ID: NCT02461355 Terminated - Stroke Clinical Trials

Transcranial Direct Current Stimulation for Post-Stroke Aphasia

Start date: June 2015
Phase: N/A
Study type: Interventional

This is a randomized, crossover design trial that will compare how anodal transcranial direct current stimulation (tDCS) versus sham tDCS administered during multiple sessions of scripting therapy affects the acquisition and retention of trained scripts.

NCT ID: NCT02461303 Terminated - Clinical trials for Klinefelter Syndrome

Fertility Assessment in Patients With Klinefelter Syndrome

Start date: January 7, 2016
Phase:
Study type: Observational

Klinefelter syndrome is characterized by primary testicular failure and progressive infertility. The objective of this study is to determine if sperm are present and can be observed in semen samples of adolescent and young adult Klinefelter patients and to determine whether the presence of sperm correlates with physical and/or clinically obtained hormone measures of pubertal development. This study was designed in order to answer the following questions: 1. Is it possible to retrieve sperm for cryopreservation from semen samples of adolescent and young adult Klinefelter patients? 2. Does the presence of sperm correlate with the physical and/or endocrine measures that are assessed during routine clinical evaluations of pubertal development in the KS patient population? 3. If sperm retrieval is possible, what is the optimal age at which sperm retrieval should be attempted?

NCT ID: NCT02461134 Terminated - Clinical trials for Chronic Graft Versus Host Disease

Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD

Start date: September 29, 2016
Phase: Phase 2
Study type: Interventional

Chronic graft versus host diseasre (GVHD) is a serious reaction that might occur in a person (the host) who has received cells or organs (graft) from another person because the graft attacks the host's cells. Currently there are no approved therapies for chronic GVHD in the USA, and patients with chroninc GVHD are treated with immunosuppressant drugs. T-lymphocytes (a type of white blood cells) are likely to play a role in the development of chronic GVHD. Due to the capacity of ponesimod to block the traffic of T-lymphocytes, ponesimod may be a new therapeutic approach to treat chroninc GVHD. The main objective of this study is to assess the effectiveness and safety of several doses of ponesimod in subjects with chronic GVHD who did not respond to standard available treatments.